The Scientific Method and Advancing Omic Technologies: Breakthroughs in Psoriatic Disease

Area of Science:

• Psoriatic disease research
• Multiomics
• Artificial intelligence

Background:

• The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 annual meeting featured a workshop on scientific fundamentals.
• Recent advancements in multiomics and artificial intelligence (AI) are transforming psoriatic disease research.

Purpose of the Study:

• To demystify complex scientific technologies for a broader audience.
• To explain the impact of multiomics and AI on understanding psoriatic diseases.
• To introduce the fundamentals, challenges, and data interpretation of these advanced technologies.

Main Methods:

• Fundamentals of genomics, transcriptomics, proteomics, and metabolomics were presented.
• Limitations and challenges associated with multiomic technologies were discussed.
• Current methodologies for presenting and interpreting big data in this field were covered.

Main Results:

• The workshop provided foundational knowledge on multiomic technologies.
• Key challenges and limitations in applying these technologies to psoriatic disease research were highlighted.
• Methods for effective big data analysis and interpretation were introduced.

Conclusions:

• Multiomics and AI represent revolutionary advances in psoriatic disease research.
• Understanding these technologies is crucial for future scientific progress.
• The workshop aimed to equip researchers with the knowledge to leverage these tools effectively.